LIGAND PHARMACEUTICALS INC — Director's Dealing 2014

Oct 10, 2014

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: LIGAND PHARMACEUTICALS INC (LGND)
CIK: 0000886163
Period of Report: 2014-10-09

Reporting Person: Sabba Stephen L (Director)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2014-10-09	Common Stock	A	2000	$43.115	Acquired	23697	Direct

Footnotes

F1: These securities, as represented in Column 5, include a grant of 1,151 restricted shares issued by the Board of Directors of the Company at the Company's annual meeting of its shareholders on June 4, 2014, which shares will vest in full on the first anniversary of the grant date. The price set forth in Column 4 reflects the weighted average of two purchases of 1,000 each, one at $42.90 and one at $43.33.